C
Cher-Rin Chong
Researcher at University of Adelaide
Publications - 36
Citations - 880
Cher-Rin Chong is an academic researcher from University of Adelaide. The author has contributed to research in topics: Perhexiline & Cardiomyopathy. The author has an hindex of 10, co-authored 34 publications receiving 668 citations. Previous affiliations of Cher-Rin Chong include University of Oxford.
Papers
More filters
Journal ArticleDOI
A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators
Derek C. Angus,Amber E. Barnato,Derek Bell,Derek Bell,Rinaldo Bellomo,Rinaldo Bellomo,Cher-Rin Chong,Timothy J Coats,Andrew Ross Davies,Andrew Ross Davies,Anthony Delaney,Anthony Delaney,Anthony Delaney,David A Harrison,Anna Holdgate,Belinda Howe,David T. Huang,Theodore J. Iwashyna,Theodore J. Iwashyna,John A. Kellum,Sandra L. Peake,Sandra L. Peake,Francis Pike,Michael C. Reade,Kathy Rowan,Mervyn Singer,Steven A R Webb,Steven A R Webb,Lisa A. Weissfeld,Donald M. Yealy,J D Young +30 more
TL;DR: EGDT is not superior to usual care for ED patients with septic shock but is associated with increased utilisation of ICU resources.
Journal ArticleDOI
Metabolic Remodeling in Diabetic Cardiomyopathy.
TL;DR: Novel pharmacological strategies targeting oxidative stress seem promising in preventing progression of diabetic cardiomyopathy, although clinical evidence is lacking and metabolic agents that lower plasma FFA or glucose, including PPARγ agonism and SGLT2 inhibition, may therefore be promising options.
Journal ArticleDOI
Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review.
Salva R. Yurista,Cher-Rin Chong,Juan J. Badimon,Daniel P. Kelly,Rudolf A. de Boer,B. Daan Westenbrink +5 more
TL;DR: In this article, the bioenergetic and pleiotropic effects of ketone bodies that could potentially contribute to its cardiovascular benefits based on evidence from animal and human studies are reviewed.
Journal ArticleDOI
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
Cher-Rin Chong,Wai Ping A. Chan,Thanh H Nguyen,Saifei Liu,Nathan E.K. Procter,Doan T.M. Ngo,Aaron L. Sverdlov,Yuliy Y. Chirkov,John D. Horowitz +8 more
TL;DR: In recent studies, it has been shown that therapeutic agents including insulin, metformin, angiotensin converting enzyme inhibitors and calcium channel blockers reduce TXNIP expression, although it is uncertain to what extentTXNIP suppression contributes to their clinical efficacy.
Journal ArticleDOI
Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors.
TL;DR: Six patients in whom TTC occurred in association with therapeutic ingestion or overdose of the serotonin/noradrenaline reuptake inhibitor venlafaxine, or its metabolite desvenlafAXine are described.